<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13G/A</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001080171</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>1</amendmentNo>
<securitiesClassTitle>Redeemable Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share</securitiesClassTitle>
<eventDateRequiresFilingThisStatement>03/31/2025</eventDateRequiresFilingThisStatement>
<issuerInfo>
<issuerCik>0001840877</issuerCik>
<issuerName>Envoy Medical, Inc.</issuerName>
<issuerCusip>29415V117</issuerCusip>
<issuerPrincipalExecutiveOfficeAddress>
<com:street1>4875 White Bear Parkway</com:street1>
<com:city>White Bear Lake</com:city>
<com:stateOrCountry>MN</com:stateOrCountry>
<com:zipCode>55110</com:zipCode>
</issuerPrincipalExecutiveOfficeAddress>
</issuerInfo>
<designateRulesPursuantThisScheduleFiled>
<designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
</designateRulesPursuantThisScheduleFiled>
</coverPageHeader>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>Aristeia Capital, L.L.C.</reportingPersonName>
<citizenshipOrOrganization>DE</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>1060922</soleVotingPower>
<sharedVotingPower>0</sharedVotingPower>
<soleDispositivePower>1060922</soleDispositivePower>
<sharedDispositivePower>0</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1060922</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>4.74</classPercent>
<typeOfReportingPerson>IN</typeOfReportingPerson>
<typeOfReportingPerson>HC</typeOfReportingPerson>
</coverPageHeaderReportingPersonDetails>
<items>
<item1>
<issuerName>Envoy Medical, Inc.</issuerName>
<issuerPrincipalExecutiveOfficeAddress>4875 White Bear Parkway, White Bear Lake, Minnesota, 55110</issuerPrincipalExecutiveOfficeAddress>
</item1>
<item2>
<filingPersonName>Aristeia Capital, L.L.C., a Delaware limited liability company (the "Reporting Person")</filingPersonName>
<principalBusinessOfficeOrResidenceAddress>The address of the principal business office of the Reporting Person is One Greenwich Plaza, Suite 300 Greenwich, CT 06830</principalBusinessOfficeOrResidenceAddress>
<citizenship>Delaware</citizenship>
</item2>
<item3>
<notApplicableFlag>N</notApplicableFlag>
<typeOfPersonFiling>IA</typeOfPersonFiling>
</item3>
<item4>
<amountBeneficiallyOwned>The Reporting Person may be deemed to be the beneficial owner of 1,060,922 Redeemable Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (the "Redeemable Warrants"), which is approximately 4.74% of the outstanding shares. This percentage was determined by dividing 1,060,922 by 22,387,541, which is the sum of (i) 21,326,619, which is the number of shares outstanding as of March 31, 2025 as reported in the Issuer's Form 10-Q for the quarterly period ended March 31, 2025, filed with the SEC on May 1, 2025 and (ii) the number of Redeemable Warrants.</amountBeneficiallyOwned>
<classPercent>4.74</classPercent>
<numberOfSharesPersonHas>
<solePowerOrDirectToVote>1,060,922</solePowerOrDirectToVote>
<sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
<solePowerOrDirectToDispose>1,060,922</solePowerOrDirectToDispose>
<sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
</numberOfSharesPersonHas>
</item4>
<item5>
<notApplicableFlag>N</notApplicableFlag>
<classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
</item5>
<item6>
<notApplicableFlag>Y</notApplicableFlag>
</item6>
<item7>
<notApplicableFlag>Y</notApplicableFlag>
</item7>
<item8>
<notApplicableFlag>Y</notApplicableFlag>
</item8>
<item9>
<notApplicableFlag>Y</notApplicableFlag>
</item9>
<item10>
<notApplicableFlag>N</notApplicableFlag>
<certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
</item10>
</items>
<signatureInformation>
<reportingPersonName>Aristeia Capital, L.L.C.</reportingPersonName>
<signatureDetails>
<signature>/s/ Andrew B. David</signature>
<title>Andrew B. David / Chief Operating Officer, Aristeia Capital, L.L.C.</title>
<date>05/15/2025</date>
</signatureDetails>
</signatureInformation>
</formData>
</edgarSubmission>
